Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Operating Results by Reportable Segment (Detail)

v3.8.0.1
Segment Information - Operating Results by Reportable Segment (Detail) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Segment Reporting Information [Line Items]          
Net Revenue $ 46,886 $ 975 $ 142,265 $ 3,865  
Direct cost of goods (505) (41) (1,852) (365)  
Sales and marketing costs (2,786) (1,244) (7,663) (4,212)  
Research and development (16,190) (8,316) (38,077) (24,559)  
General and administrative (12,318) (7,620) (28,827) (21,202)  
National Expenses 79,489 17,221 215,638 50,338  
Segment loss from operations (32,603) (16,246) (73,373) (46,473)  
Segment assets 245,091 145,421 245,091 145,421 $ 170,731
Dermatology Products Sales [Member]          
Segment Reporting Information [Line Items]          
Net Revenue 2,170 429 8,309 1,793  
Direct cost of goods (505) (41) (1,852) (365)  
Sales and marketing costs (2,786) (1,244) (7,663) (4,212)  
Research and development   0   0  
General and administrative (349) (422) (961) (1,338)  
National Expenses 0   0    
Segment loss from operations (1,470) (1,278) (2,167) (4,122)  
Segment assets 7,362 2,657 7,362 2,657  
Pharmaceutical And Biotechnology Product Development [Member]          
Segment Reporting Information [Line Items]          
Net Revenue 350 546 1,393 2,072  
Direct cost of goods 0 0 0 0  
Sales and marketing costs 0 0 0 0  
Research and development (16,190) (8,316) (38,077) (24,559)  
General and administrative (11,969) (7,198) (27,866) (19,864)  
National Expenses 0   0    
Segment loss from operations (27,809) (14,968) (64,550) (42,351)  
Segment assets 160,038 103,225 160,038 103,225  
National [Member]          
Segment Reporting Information [Line Items]          
Net Revenue 44,366 0 132,563 0  
Direct cost of goods   0   0  
Sales and marketing costs   0   0  
Research and development   0   0  
General and administrative   0   0  
National Expenses (47,690)   (139,219)    
Segment loss from operations (3,324) 0 (6,656) 0  
Segment assets $ 77,691 $ 39,539 $ 77,691 $ 39,539